Eight-year disease-free survival in clear cell adenocarcinoma of the urethra with surgery alone: a case report and literature review - Scorecard - MDSpire
Advertisement
Eight-year disease-free survival in clear cell adenocarcinoma of the urethra with surgery alone: a case report and literature review
Clinical Scorecard: Long-term disease-free survival following surgical intervention in a case of clear cell adenocarcinoma of the urethra: a case study and review of existing literature
At a Glance
Category
Detail
Condition
Clear cell adenocarcinoma of the urethra (CCAU)
Key Mechanisms
Aggressive cancer with poor prognosis; diagnosis confirmed via urine cytology and imaging.
Target Population
Women, primarily aged 35-80 years.
Care Setting
Multidisciplinary surgical intervention and follow-up care.
Key Highlights
Patient achieved 8 years of disease-free survival post-surgery.
Initial diagnosis confirmed through urine cytology and imaging.
Surgical treatment included laparoscopic radical cystectomy and lymph node dissection.
No adjuvant therapy was administered after surgery.
Follow-up showed gradual reduction in lymph node size without recurrence.
Guideline-Based Recommendations
Diagnosis
Histopathological examination is the gold standard for diagnosis.
Urine cytology may serve as a non-invasive diagnostic tool.
Management
Surgical resection is the main treatment for CCAU.
Radiotherapy and chemotherapy showed no survival benefit.
Monitoring & Follow-up
Regular follow-up every three months is advised.
Risks
CCAU has a poor prognosis with reported 5-year survival rates below 50%.
Patient & Prescribing Data
39-year-old female with clear cell adenocarcinoma of the urethra.
Surgery alone led to long-term disease-free survival.
Clinical Best Practices
Consider multidisciplinary consultation for treatment planning.
Monitor for potential complications such as pyelonephritis post-surgery.
